Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
November 28th, 2008
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Thomas C. Wessel, M.D., Ph.D., has joined the Company as Chief Medical Officer, reporting to Ron Cohen, M.D., President and CEO. In this role, Dr. Wessel will have responsibility for the Company's Clinical Development and Operations, Regulatory Affairs, Biostatistics, Data Management and Drug Safety functions. Previously, Dr. Wessel was Senior Vice President of Clinical Research at Sepracor, Inc., where he led the central nervous system (CNS) and respiratory medicine development teams, including clinical research and operations, clinical pharmacology, drug safety and medical writing. During this time, he served as...
Source: Health Business Week (2008-11-28)
|
